Delaying Initiation of Antiretroviral Therapy for Cryptococcal Meningitis Improves Survival.
Mortality; Comorbidity; Survival; Human; Africa; Meningitis; Anti-HIV Agents; Delayed Onset; Anti-Retroviral Agents – Therapeutic Use; Cryptococcal – Drug Therapy
Watkins Richard R
Infectious Disease Alert
2014
2014-08
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Dual Combination ART with Cabotegravir and Rilpivirine Is Effective for Maintaining HIV Virological Suppression.
Adverse Drug Event; Anti-HIV Agents; Antiviral Agents – Therapeutic Use; Drug Combinations – Therapeutic Use
Results of the phase 2 LATTE study show that after 24 weeks of induction triple therapy, maintenance therapy with cabotegravir (a long-acting dolutegravir analogue) and rilpivirine led to virological suppression in 82% of patients, compared to 71 % who received efavirenz plus two NRTIs.
Watkins Richard R
Infectious Disease Alert
2015
2015-11
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).